Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-16

Clinical Trial Update: The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating inorganic nitrate to prevent contrast-induced nephropathy; completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inorganic nitrate (inorganic nitrate)

Snippet

Sponsor: Barts & The London NHS Trust | Conditions: Contrast-induced Nephropathy, Acute Kidney Injury | Phase 2 | Status: COMPLETED